2026 NPPES data Gynecologic Oncology Physician NPI 1144648320 MD
Verify on CMS →

SHARISKA HARRINGTON, MD

Gynecologic Oncology Physician in ROCHESTER, Minnesota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
105
Medicare Part D claims · 26 beneficiaries · Gynecologic Oncology Physician avg: 188
MIPS score
90.7537/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$112.33
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SHARISKA HARRINGTON, MD is a Gynecologic Oncology Physician ([object Object]) practicing in ROCHESTER, Minnesota with a Medicare Part D prescribing footprint of 105 claims across 26 beneficiaries . Their CMS MIPS Final Score of 90.7537/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $112.33 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SHARISKA HARRINGTON, MD reported a CMS MIPS final score of 90.7537 out of 100, above the 83.1 national average, and filed 105 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SHARISKA HARRINGTON, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SHARISKA HARRINGTON, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 04/03/2014

NPI 1144648320

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

105 44% vs specialty avg

2023 prescription claims

Specialty avg: 188

MIPS final score

90.7537/100 7.653700000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Minnesota

How Gynecologic Oncology Physician compares to other specialties among Minnesota providers

Minnesota providers

Gynecologic Oncology Physician share within Minnesota

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within Minnesota

Medicare quality performance — MIPS

SHARISKA HARRINGTON, MD's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average

High performer (top quartile)
MIPS Final Score
90.7537/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Gynecologic Oncology Physician) — 90.7537/100 vs national avg 83.1

0%100%National avg83%90.8%
MIPS final score (Gynecologic Oncology Physician) — 90.7537/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHARISKA HARRINGTON, MD is a Gynecologic Oncology Physician provider practicing in ROCHESTER, Minnesota, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1144648320. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SHARISKA HARRINGTON, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 200 1ST ST SW, ROCHESTER, MN, 55905, with a listed phone of (507) 284-2511. NPI 1144648320 was issued on 04/03/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HARRINGTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 105 prescription claims written by this provider, covering 26 Medicare beneficiaries and totaling roughly $140K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.7537/100 for the 2023 performance year (Quality 74.643), compared with the national average of 83.1.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

200 1ST ST SW
ROCHESTER, MN 55905

Provider Details

NPI 1144648320
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Female
NPI Issued 04/03/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.7537
Final Score
Avg: 83.1
74.643
Quality
99
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where SHARISKA HARRINGTON, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MAYO CLINIC
ROCHESTER, MN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SHARISKA HARRINGTON, MD. Source: openpaymentsdata.cms.gov.

Total received

$112

Largest payer

Myriad Genetic Laboratories, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

105
Total Claims
$140K
Total Drug Cost
26
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
114
Total Day Supply
1,864
Generic Drug Cost
$1K
Antibiotic Claims
13

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.18
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Dexamethasone
14
Lynparza
Olaparib
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How SHARISKA HARRINGTON, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

SHARISKA HARRINGTON, MD's 105 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in Minnesota

Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as HARRINGTON.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHARISKA HARRINGTON, MD's specialty?
SHARISKA HARRINGTON, MD specializes in Gynecologic Oncology Physician and practices in ROCHESTER, Minnesota. Credentials: MD.
How much does SHARISKA HARRINGTON, MD prescribe under Medicare Part D?
In 2023, SHARISKA HARRINGTON, MD wrote 105 Medicare Part D claims totaling $140K in drug costs for 26 beneficiaries.
What is SHARISKA HARRINGTON, MD's Medicare quality score?
SHARISKA HARRINGTON, MD has a CMS MIPS Final Score of 90.7537/100 (Quality: 74.643). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SHARISKA HARRINGTON, MD located?
SHARISKA HARRINGTON, MD is located at 200 1ST ST SW, ROCHESTER, MN, 55905. Phone: (507) 284-2511.
What is SHARISKA HARRINGTON, MD's NPI number?
SHARISKA HARRINGTON, MD's National Provider Identifier (NPI) is 1144648320, issued on 04/03/2014.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does SHARISKA HARRINGTON, MD prescribe most often?
Based on 2023 Medicare Part D data, SHARISKA HARRINGTON, MD's most frequently prescribed drugs include Dexamethasone, Lynparza. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHARISKA HARRINGTON, MD accept Medicare?
SHARISKA HARRINGTON, MD appears in CMS Medicare data with 105 Part D claims and 26 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHARISKA HARRINGTON, MD's credentials?
SHARISKA HARRINGTON, MD's NPI is 1144648320 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology